Exploring Parallel & Drug-Dx Co-Development to Shape Effective Therapeutic Models
Time: 1:50 pm
day: Day 2 Track A PM
Details:
- Understanding the implications and complexity of DDR loss of function
- Discussing the impact and challenge identifying DDR reversions in patients treated with next generation DNA repair inhibitors
- Next generation liquid biopsies for monitoring and diagnosing DDR LoF and resistance
